COGENT BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.5 USD | -3.13% |
|
-6.61% | +10.54% |
| 02-27 | North American Morning Briefing : Stock Futures -2- | DJ |
| 02-26 | Citigroup Adjusts Price Target on Cogent Biosciences to $13 From $11, Maintains Buy Rating | MT |
Chart calendar Cogent Biosciences, Inc.
e19d7410c203135421eb244de29f68a4.H7XVsjNNiEKXTDlqlA8TqtefcSbcgRaT4wEJ06NLpyM.LNKx3gYnvjbSJXFb2WRM6ZXNIVWxy26jiUI8tZYK8kZmwZT1SXi-Df0GAQ~fea574a27f4a6d3ad1d3c3f438b00381
Upcoming events on Cogent Biosciences, Inc.
Past events on Cogent Biosciences, Inc.
| 09/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract Number: 4486 |
| 26/02/2024 13:00 | Q4 2023 Earnings Release |
| 25/02/2024 14:45 | American Academy of Allergy, Asthma & Immunology Meeting - Poster Number: 688 |
| 25/02/2024 14:45 | American Academy of Allergy, Asthma & Immunology Meeting - Poster Number: 694 |
| 23/02/2024 13:00 | American Academy of Allergy, Asthma & Immunology Meeting |
| 10/01/2024 00:30 | JPMorgan Healthcare Conference |
| 12/12/2023 02:00 | American Society of Hematology Meeting |
| 11/12/2023 13:00 | American Society of Hematology Meeting |
| 09/12/2023 18:30 | American Society of Hematology Meeting |
| 09/12/2023 17:30 | American Society of Hematology Meeting |
| 07/12/2023 18:00 | San Antonio Breast Cancer Symposium - Identification of a novel |
| 07/12/2023 18:00 | San Antonio Breast Cancer Symposium - Preclinical in vitro |
| 28/11/2023 19:30 | Piper Sandler Healthcare Conference |
| 15/11/2023 12:00 | Jefferies London Healthcare Conference |
| 04/11/2023 09:00 | Connective Tissue Oncology Society Meeting |
| 02/11/2023 13:00 | Q3 2023 Earnings Release |
| 14/10/2023 17:30 | AACR-NCI-EORTC International Conference - Abstract Number: 35488 |
| 13/09/2023 13:10 | Morgan Stanley Global Healthcare Conference |
| 08/08/2023 13:00 | Q2 2023 Earnings Release |
| 08/06/2023 14:30 | Jefferies Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7,87 7,92 -0.65% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -206 -147 -40.34% | -178 |
|
EBIT Million USD | Released Forecast Spread | -82,2 -83,4 1.47% | -75,6 -70,2 -7.57% | -148 -142 -3.95% | -208 -202 -3.24% | -228 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -74,8 -77,2 3.14% | -72,3 -67,1 -7.68% | -140 -138 -1.81% | -192 -188 -2.29% | -215 |
|
Net income Million USD | Released Forecast Spread | -179 -77,2 -132.03% | -72,3 -67,8 -6.63% | -140 -138 -1.46% | -192 -189 -1.77% | -220 |
|
EPS USD | Released Forecast Spread | -16,2 -3,54 -356.78% | -1,87 -1,70 -10.11% | -2,39 -2,34 -2.01% | -2,42 -2,30 -5.01% | -2,00 |
| Announcement Date | 16/03/21 | 15/03/22 | 14/03/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -57,6 -3,87 -1387.43% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -25,6 -20,3 -26.15% | -31,4 -24,6 -27.81% | -35,9 -32,0 -12.03% | -36,8 -36,6 -0.51% | -43,7 -38,1 -14.73% | -43,2 -41,6 -3.97% | -47,1 -43,1 -9.16% | -59,6 -46,0 -29.57% | -58,2 -53,2 -9.49% | -55,8 | -56,9 | -57,2 | -58,1 | -52,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,9 -19,8 -26.1% | -30,6 -24,0 -27.7% | -34,9 -31,5 -10.76% | -35,1 -35,7 1.8% | -39,6 -37,1 -6.76% | -38,6 -40,1 3.86% | -44,1 -40,9 -7.79% | -55,4 -43,7 -26.63% | -54,4 -50,1 -8.58% | -52,5 | -53,4 | -54,0 | -55,2 | -48,6 |
|
Net income Million USD | Released Forecast Spread | -24,9 -20,4 -21.94% | -30,6 -24,6 -24.41% | -34,9 -32,0 -9.28% | -35,1 -36,4 3.58% | -39,6 -37,6 -5.39% | -38,6 -41,2 6.35% | -44,1 -41,4 -6.36% | -55,4 -44,7 -23.99% | -54,4 -51,0 -6.58% | -53,4 | -54,5 | -55,4 | -56,6 | -48,6 |
|
EPS USD | Released Forecast Spread | -0,62 -0,45 -36.77% | -0,68 -0,53 -29.52% | -0,71 -0,66 -8.12% | -0,50 -0,51 2.6% | -0,56 -0,52 -8.29% | -0,54 -0,56 4.3% | -0,59 -0,54 -8.37% | -0,64 -0,50 -28.32% | -0,63 -0,56 -13.4% | -0,51 | -0,49 | -0,50 | -0,50 | -0,35 |
| Announcement Date | 15/03/22 | 10/05/22 | 09/08/22 | 14/11/22 | 14/03/23 | 09/05/23 | 08/08/23 | 02/11/23 | 26/02/24 | - | - | - | - | - |
More events
Past sector events for Cogent Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- COGT Stock
- Calendar Cogent Biosciences, Inc.
